Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
national blog main
7
×
startups
7
×
biotech
life sciences
national top stories
san francisco blog main
boston blog main
deals
san francisco top stories
boston top stories
san diego blog main
san diego top stories
detroit blog main
detroit top stories
investing
new york blog main
new york top stories
san francisco
vc
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
crispr therapeutics
entrepreneurship
fda
funding
gene therapy
indiana blog main
indiana top stories
innovation
national
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
sherlock biosciences
What
today
7
×
drug
new
available
based
big
bio
biotech
crispr
future
launch
medical
roundup
startup
technology
treatments
acquisitions
advance
ahead
aiming
albert
ambien
ambys
american
ann
announced
annual
approval
arbor
asco
attendees
attention
balance
biggest
biologic
biology
biome
biosciences
blood
bourla
Language
unknown
unset
Current search:
today
×
photo
×
" national blog main "
×
startups
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs